LOINC
Version 2.73

95826-4SARS-CoV-2 (COVID-19) RNA panel - Saliva (oral fluid) by NAA with probe detectionActive

Term Description

This panel contains results for the detection of Severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2), initially known as 2019-Novel Coronavirus (2019-nCoV), in a saliva specimen using nucleic acid amplification assays with probe-based detection for the diagnosis of Coronavirus Disease 2019 (COVID-19).
Source: Regenstrief LOINC

Part Descriptions

LP417539-6   SARS coronavirus 2 RNA panel
The Severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2), first known as 2019 Novel Coronavirus (2019-nCoV), was first identified as the cause of a respiratory illness outbreak, later defined as Coronavirus Disease 2019 (COVID-19), in Wuhan, China. The full genome of the SARS-CoV-2 that causes COVID-19 was first posted by Chinese health authorities in GenBank, the NIH genetic sequence database, and in the Global Initiative on Sharing All Influenza Data (GISAI) portal. This facilitated detection of the virus globally with subsequent sequences being nearly identical, suggesting a single, recent emergence from a virus related to bat coronaviruses and the SARS coronavirus. Real time Reverse Transcription-Polymerase Chain Reaction (rRT-PCR) tests targeting regions within genes, including RdRp, S, N, M, and E genes, specific to SARS-CoV-2 have been developed by the Centers for Disease Control and Prevention (CDC), the World Health Organization (WHO) and others for the diagnosis of COVID-19. Some assays only detect SARS-CoV-2 and other assays detect other strains (e.g. SARS-CoV) that are genetically similar.[CDC:coronavirus/2019-ncov][https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/laboratory-guidance] Source: Regenstrief LOINC

LP7565-7   Saliva
Saliva is produced primarily by the parotid, submaxillary, and sublingual glands. It is secreted at the rate of 0-3 milliliters per minute which is affected by various factors including anxiety, hydration and hunger. Oral fluid is broadly used to test for drugs of abuse in employment and forensic settings, and is especially useful since it is difficult to adulterate, is quick and is non-invasive. Oral fluid is used to test a variety of analytes, including to test alcohol, HIV and other antibodies, therapeutic drugs and steroids, but its primary use is to test for drugs of abuse including amphetamines, cocaine and metabolites, opioids, methadone, cannabis and heroin.[PMID:17268583] Source: Regenstrief LOINC

Panel Hierarchy
Details for each LOINC in Panel LHC-Forms

LOINC Name R/O/C Cardinality Example UCUM Units
95826-4 SARS-CoV-2 (COVID-19) RNA panel - Saliva (oral fluid) by NAA with probe detection
Indent95425-5 SARS-CoV-2 (COVID-19) N gene [Presence] in Saliva (oral fluid) by NAA with probe detection
Indent96448-6 SARS-CoV-2 (COVID-19) N gene [Presence] in Saliva (oral fluid) by Nucleic acid amplification using CDC primer-probe set N1
Indent96958-4 SARS-CoV-2 (COVID-19) N gene [Presence] in Saliva (oral fluid) by Nucleic acid amplification using CDC primer-probe set N2
Indent95824-9 SARS-CoV-2 (COVID-19) ORF1ab region [Presence] in Saliva (oral fluid) by NAA with probe detection
Indent96091-4 SARS-CoV-2 (COVID-19) RdRp gene [Presence] in Saliva (oral fluid) by NAA with probe detection
Indent96765-3 SARS-CoV-2 (COVID-19) S gene [Presence] in Saliva (oral fluid) by NAA with probe detection
Indent94845-5 SARS-CoV-2 (COVID-19) RNA [Presence] in Saliva (oral fluid) by NAA with probe detection
Indent95823-1 SARS-related coronavirus E gene [Presence] in Saliva (oral fluid) by NAA with probe detection

Fully-Specified Name

Component
SARS coronavirus 2 RNA panel
Property
-
Time
Pt
System
Saliva
Scale
-
Method
Probe.amp.tar

Additional Names

Short Name
SARS-CoV-2 RNA Pnl Sal NAA+probe
Display Name
SARS-CoV-2 (COVID-19) RNA panel NAA+probe (Sal)
Consumer Name Alpha
SARS-CoV-2 (COVID-19) RNA Panel, Saliva

Basic Attributes

Class
PANEL.MICRO
Type
Laboratory
First Released
Version 2.69
Last Updated
Version 2.70
Order vs. Observation
Order
Panel Type
Panel

Reference Information

Type Source Reference
Webcontent Lab Tests Online®Copyright Copyright © 2021 Lab Tests Online. All rights reserved. Coronavirus (COVID-19) Testing

Member of these Groups

LG51017-8 SARSCoV2 detection
LG51019-4 SARSCoV2 molecular detection

Language Variants Get Info

zh-CNChinese (China)
SARS 冠状病毒 2 RNA 组套:-:时间点:唾液:-:探针法.基因扩增.靶向
nl-NLDutch (Netherlands)
SARS-CoV-2 RNA panel:-:moment:speeksel:-:moleculaire techniek (PCR)
fr-CAFrench (Canada)
Coronavirus 2 du SRAS, ARN:-:Temps ponctuel:Salivaire:-:Sonde avec amplification de la cible
fr-FRFrench (France)
Coronavirus SARS-CoV-2 ARN panel:-:Ponctuel:Salive:-:PCR amplification de cible
de-DEGerman (Germany)
SARS-Coronavirus 2 RNA (Liste):-:Zeitpunkt:Speichel:-:Zielfragmentamplifikation mit Sondendetektion
it-ITItalian (Italy)
SARS coronavirus 2, panel RNA:-:Pt:Saliva:-:Sonda.amp.tar
es-MXSpanish (Mexico)
Panel de ARN del coronavirus 2 del SARS:-:Punto temporal:Saliva:-:Amplificación de ácidos nucleicos con detección de sonda
es-ESSpanish (Spain)
Panel de ARN del SARS-CoV-2 (COVID-19):Propiedades mixtas (sólo paneles):Punto temporal:Saliva:-:Sonda con amplificación dirigida

LOINC FHIR® API Example - CodeSystem and Questionnaire Requests Get Info

https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=95826-4 https://fhir.loinc.org/Questionnaire/?url=http://loinc.org/q/95826-4